Cost-effectiveness data on biologics needed.
Sheridan
Cormac
C
Katsnelson
Alla
A
D001688:Biological Products / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis / Q000191:economics / Q000379:methods; D004345:Drug Industry / Q000191:economics*; D004358:Drug Therapy / Q000191:economics*; D005062:European Union; D018803:Models, Economic; D004364:Pharmaceutical Preparations / Q000191:economics*; D014481:United States
D001688:Biological Products; D004364:Pharmaceutical Preparations